HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- New uses for an old drug
-
- ADT not associated with cardiovascular death
- Dasatinib plus docetaxel active in castration-resistant prostate cancer
- HPV DNA testing recommended during cervical screening for 30-year-old women
- Low-dose interleukin sustained T-cell expansion in graft-versus-host disease patients
- Prolonged statin therapy reduced vascular events without increasing cancer risk
- Reorganization of hospital services benefited survival of gynecological cancer patients
- Toxicities related to survival in RCC patients receiving sunitinib, sorafenib
- Two carboplatin regimens show similar efficacy in advanced urothelial cancer
-
- Ultrasonographic screening increased detection of epithelial ovarian cancer
- Warfarin, diabetes medications implicated in emergency hospitalization among elderly
- A 43-year-old female with multiple plasmacytomas Ramya Varadarajan, MD
- Prescription assistance available for patients who cannot afford anticoagulants Beth Waldron, MA; Stephan Moll, MD
- Debate continues on Medicare physician payment cuts
- Papillary tumor of the pineal region Munir Ghesani, MD, FACNM; Chun-Der Li, MD; Yinghua Pang, MD; Francisco Delara, MD; Lauren Moomjian, MD; Ali Noor, MD; Shain Wallis, DO
- Innovations in caring for the patient with advanced cancer Stephanie M. Harman, MD, FACP